Lower Risk of Cardiovascular (CV) Events and Death in Men Receiving ADT by Gonadotropin Releasing Hormone (GnRH) Antagonist, Degarelix, Compared with Luteinising Hormone-releasing (LHRH) Agonists
                                                
            
            
                
                                    CUA Online Library. Klotz L.                     06/25/13;                    31329; MP-07.16                
                
                
                 
                    Disclosure(s): Study supported by Ferring Inc.          
                
                
            
        
					
						
    
    
	CLICK HERE TO LOGIN
REGULAR CONTENT
	REGULAR CONTENT
    
            Login now to access Regular content available to all registered users.
    
							
										
                Rate & Comment (0)
            
                    
        
    
                        Code of conduct/disclaimer available in General Terms & Conditions
                    
                {{ help_message }}
    {{filter}}
                 
                             
        
